Altre lingue AngioDynamics, Inc.

Azioni

ANGO

US03475V1017

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
5,81 ^USD	+0,52%		-7,19%	-25,89%

05/04	ANGIODYNAMICS, INC. : il giudizio da Oppenheimer è ora al rialzo	ZM
04/04	Le azioni di AngioDynamics sono salite dopo i risultati del terzo trimestre fiscale e l'autorizzazione della FDA per il dispositivo	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Inflation Data, -2-	08/04
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results, Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture	05/04
AngioDynamics Receives 510(k) Clearance for AlphaVac F18 System in Treatment of PE	05/04
AngioDynamics Shares Jump After Fiscal Q3 Results, FDA Clearance For Device	04/04
AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System	04/04
AngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatment	04/04
AngioDynamics: Fiscal Q3 Earnings Snapshot	04/04
Earnings Flash (ANGO) ANGIODYNAMICS Reports Q3 Revenue $66M	04/04
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture	04/04
AngioDynamics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	04/04
AngioDynamics, Inc. Reports Consolidated Goodwill Impairment for Third Quarter Ended February 29, 2024	04/04
AngioDynamics, Inc. Provides Sales Guidance for the Fiscal Year 2024	04/04
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE	04/04
AngioDynamics, Inc. Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
AngioDynamics Settles Patent Dispute with Becton, Dickinson Affiliate	02/04
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.	01/04
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co	01/04
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024	19/03
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference	06/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue AngioDynamics, Inc.

Azioni

ANGO

US03475V1017

Altre lingue

Filtri